SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

HSBCs bearish view on CoreWeave has amplified concerns about its debt-heavy data-center expansion, rising financing costs, and potentially slowing AI demand. Traders are split between buying the selloff and anticipating a short squeeze, and warning that credit and insider-selling risks could prolong the decline.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as crude swings on Middle East supply concerns, including reported tanker and energy-infrastructure attacks, while traders also weigh Ukrainian strikes on Russian oil assets. The community is split between expecting supply risks to keep oil elevated and betting that diplomacy, supply relief, or an overextended rally will bring a pullback.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs slide to fresh lows is being tied by traders to weakening confidence in Trump and the approaching midterms, alongside concerns about the companys limited business fundamentals and Truth Social. The discussion is broadly bearish, though some traders view the decline as a possible short-term trading bounce.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

A European Medicines Agency committee recommendation for Lillys Foundayo obesity pill is fueling a breakout to fresh highs, with traders also focused on the upcoming earnings report. Bulls see the pill as expanding Lillys obesity-market reach, while skeptics question whether the gains will hold and point to competition from Novo Nordisk.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention for a sharp rebound after a tech-led selloff, which traders link to unconfirmed reports of potential U.S.-Iran talks and easing oil prices. The community is split between viewing the move as a bullish reversal and warning it may be a bull trap amid persistent volatility and concerns about tech and AI stocks.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers rebound toward a one-year high and the $30 level is driving discussion, with traders focused on whether the move can break through resistance. Some see momentum from a defensive-sector rotation and pipeline developments ahead of earnings, while others say the stock needs stronger news to sustain a breakout.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapport Therapeutics is drawing attention after RAP-219 met the primary and secondary endpoints in a Phase 2 trial for acute bipolar mania. Traders are divided: bulls view the results as proof of concept and note plans for Phase 3, while skeptics question the modest efficacy and point to agitation and discontinuation concerns as the initial rally faded.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicors Q3 results and outlook are drawing attention, with traders focusing on strong revenue growth, AI-related demand, and recurring royalties from its Vertical Power Delivery licensing business. The reaction is broadly bullish after the shares rise, though some traders question the valuation and weigh the earnings details against capacity constraints and uncertainty around how durable royalty revenue will be.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is caught in a sharp neocloud and AI-infrastructure selloff as traders weigh Gartners warning about the sectors economics and broader concerns over debt, funding, and project execution. The community is split between expecting further declines and buying an oversold dip; some cite the CEOs assurances about data-center financing, while others point to Horizon 2 delays and weak price action.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

A broad selloff in AI-infrastructure and neocloud stocks, fueled by concerns about whether heavy buildout spending can earn adequate returns and be financed sustainably, has driven NBIS discussion; traders also cite contagion from CoreWeave and Gartners warning about the sector. The community is split between viewing NBISs rebound as an oversold buying opportunity and expecting further declines, with funding needs and upcoming results central to the debate.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bullish Two Hundred Day Moving Average Cross - BBWI

In trading on Thursday, shares of Bath & Body Works Inc (Symbol: BBWI) crossed above their 200 day moving average of $19.83, changing hands as high as $20.80 per share. Bath & Body Works Inc shares are currently trading up about 9.4% on the day. The chart below shows t...

Zacks.com featured highlights include Cracker Barrel, Best Buy, Beazer Homes USA, Cleveland-Cliffs and Bath & Body Works

Cracker Barrel, Best Buy, Beazer Homes, Cleveland-Cliffs and Bath & Body Works draw broker support amid market uncertainty, with earnings beats and growth initiatives.

5 Stocks Liked by Brokers Amid the Prevalent Uncertain Scenario 

Amid market uncertainty, five broker-favored stocks, CBRL, BBY, BZH, CLF and BBWI, stand out for earnings performance, growth initiatives & favorable valuations.


Bath & Body Works (BBWI) Surges 8.7%: Is This an Indication of Further Gains? (Revised)

Bath & Body Works (BBWI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

BBWI's Product Innovation Supports Pricing as Consumers Seek Value

Bath & Body Works is leaning on upgraded formulas, packaging and new fragrances to support pricing as value-conscious consumers pressure broader sales.

Bath & Body Works (BBWI) Surges 8.7%: Is This an Indication of Further Gains?

Bath & Body Works (BBWI) Down 9.9% Since Last Earnings Report: Can It Rebound?

Bath & Body Works (BBWI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

New Strong Sell Stocks for September 16th

AGCO, BSX and BBWI have been added to the Zacks Rank #5 (Strong Sell) List on September 16th, 2026.

BBWI Stock Jumps 7.5% on Q2 Earnings Beat, Fiscal 2026 Outlook Raised

Bath & Body Works stock surges 7.5% after a Q2 earnings beat, stronger direct sales and a higher FY'26 outlook signal improving momentum.

These Analysts Slash Their Forecasts On Bath & Body Works Following Q2 Results

Bath & Body Works (BBWI) reported strong Q2 results and raised its FY26 EPS guidance. Analysts have mixed opinions on the stock. BBWI shares fell 2.9%.read more...

Bath & Body Works, Inc. is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. The company was founded by Leslie Herbert Wexner in 1963 and is headquartered in Columbus, OH.

Bath & Body Works Inc

BBWI Stock Draws Investor Cheer After Upbeat Q1 – But CEO Says Performance Remains Below What The Brand Is Capable Of Delivering

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>The company maintained its full-year 2026 guidance with net sales expected to decline between 4.5% and 2.5%.</li><li>Bath &amp; Body Works Chief Financial Officer Eva Boratto will step down effective June 12 to pursue another professional opportunity.</li><li>The company also expects 2026 adjusted earnings of $2.40 to $2.65 per share and free cash flow of about $600 million.</li></ul>Shares of Bath &amp; Body Works, Inc. (BBWI) rose over 10% premarket on Wednesday after the company reported a strong quarter, but the specialty retailer's chief indicated that performance remains below what the brand should deliver.<a href="https://stocktwits.com/symbol/BBWI">Bath &amp; Body Works</a> reported first-quarter (Q1) net sales of $1.4 billion, beating Wall Street Expectations of $1.36 billion, while adjusted net earnings of $0.32 per share surpassed analysts’ estimate of $0.29, according to the Koyfin data.Despite the Q1 beat, Daniel Heaf, chief executive officer at Bath &amp; Body Works, said, “Our first-quarter results exceeded guidance, but remain below the standard our brand is capable of delivering.”Heaf also added that the&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2026/05/27/3301747/0/en/bath-body-works-reports-first-quarter-results-exceeding-guidance-and-progress-against-the-consumer-first-formula.html">company</a> has been bolstering its hero categories, modernizing the brand, and expanding its reach. These efforts have begun to resonate with its customers, and the company has seen early proof points as a result.“We believe that the foundation we are building will drive improved performance over time, with the impact expected to build through the balance of 2026 and more meaningfully into 2027,” said Heaf.<h2 class="st-heading-2">BBWI Reiterates 2026 Guidance</h2>Bath &amp; Body Works maintained its full-year 2026 guidance, with net sales expected to decline between 4.5% and 2.5% compared to $7.29 billion in fiscal 2025.The company also expects 2026 adjusted earnings of $2.40 to $2.65 per share and free cash flow of about $600 million. Bath &amp; Body Works did not assume share repurchases or tariff refunds for its guidance projections.&nbsp;For the second quarter, the company forecasts net sales&nbsp;to decline between 3% and 5%&nbsp;and earnings of $0.20&nbsp;to $0.25 per share.<h2 class="st-heading-2">BBWI CFO Departure</h2>The company also announced that Chief Financial Officer Eva Boratto will step down effective June 12 to pursue another professional opportunity.Tom Javitch, a 16-year veteran of Bath &amp; Body Works and former L Brands finance leader, has been appointed interim CFO while the company looks for a new CFO through a leading executive search firm.<h2 class="st-heading-2">What Retail Thinks Of BBWI</h2>On Stocktwits, retail sentiment surrounding the stock has improved to ‘extremely bullish’ from ‘bullish’, while message volume stayed ‘high‘ over the past 24 hours.Shares of&nbsp;Bath &amp; Body Works have declined more than 14% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/mnts-stock-200-dma-fund-raising-spacex-momentum/cZggBamRerG">MNTS Stock Surged Past Its 200-DMA Yesterday – Today’s Pre-Market Jump Proves It Could Be A Conviction Move</a>

 A Bath & Body Works logo is displayed outside one of their stores on March 23, 2025 in San Diego, California. (Photo by Kevin Carter/Getty Images)

Bath & Body Works reported first-quarter net sales of $1.4 billion, beating Wall Street Expectations of $1.36 billion.

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$20.28
Prev Close	$19.84
Open	$19.98
Dividend Yield	3.67%
50-Day Moving Average	$18.14
Beta	1.41
Avg. Volume	6.48M
PE Ratio	5.15

52-Week High	$27.40
52-Week Low	$14.28
Market Capitalization	$4B
EPS (Annual)	$3.11
Price to Book	-3.80
Revenue Per Employee	$120,046.10

Feed

News

Sentiment

Earnings

Fundamentals

Info

BBWI Fundamentals